5Mouslech Z, Valla V. Endocannabinoid system:an overview of its potential in current medical practice [ J ]. Neuro Endocrinol Lett, 2009,30(2) :153 - 179.
6Schlicker E, Kathmann M. Modulation of transmitter release via presynaptic cannabinoid receptors[ J ]. Trends Pharmacol Sci, 2001,22:565 - 572.
8Przybyla JA, Watts VJ. Ligand-induced regulation and localization of cannabinoid CB1 and dopamine D2L receptor heterodimers [J]. J Pharmacol Exp Ther,2010,332(3) :710 -719.
9Hasseldam H, Johansen FF. Neuroprotection without immunomod- ulation is not sufficient to reduce first relapse severity in experi- mental autoimmune encephalomyelitis[ J]. Neuroimmunomodula- tion,2010,17 (4) :252 -264.
10Riebe CJ, Lee TT, Hill MN, et al. Precipitated withdrawal counters the adverse effects of subchronic cannabinoid administration on male rat sexual behavior [ J 1. Neurosci Lett, 2010,472 ( 3 ) : 171 - 174.
3Howlett AC, Barth F, Bormer TI, et al. International union of pharmacology XXVII classification of caunabinoid receptors [J]. Pharmacol Rev, 2002, 54(9): 161-202.
5Sami S, Vaqar M, Deeba N, et al. Cannabinoids for cancer treatment: progress and promise[J]. Cancer Res, 2008, 68(2): 339-42.
6Ibrahim MM, Porreca F, Lai J, et al. CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids [J]. Proc Natl Acad Sci, 2005, 102 (8): 3093-8.
7Sonja S, Martin S, Dieter M. Distribution of carmabinoid receptor 1 (CB1) and 2 (CB2) on sensory nerve fibers and adnexal structures in human skin[J]. J Dermatological Sci, 2005, 38(8): 177-88.
8Casanova ML, Blazquez C, Martinez-Palacio J, et al. Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors[J]. J Clin Invest, 2003, 111 (1): 43-50.
9Blazquez C, Carracedo AK, Barrado LL, et al. Cannabinoid receptors as novel targets for the treatment ofmelanoma[J].FASEB J, 2006, 12 (20): 1-10.
10Sami S, Farrukh A. Cannabinoid receptor as a novel target for the treatment of prostate cancer [J]. Cancer Res, 2005, 65 (5): 1635-41.
